An Edinburgh medical devices firm has raised £4.5 million to bring its “game-changing” dental system to the lucrative US market.
Calcivis has closed the final part of its multi-million-pound equity fundraise as it gears up to launch its system for assessing and treating tooth decay in the world’s largest dentistry market.
The company plans to access the US market next year, subject to receiving pre-market approval (PMA) from the government-run Food and Drug Administration (FDA).
The latest funding round was led by Edinburgh business angel syndicate Archangels and supported by the Scottish Investment Bank, the investment arm of Scottish Enterprise, both of which are longstanding supporters of the business.
Read more HERE.
